PRESS




OCTOBER 1, 2014
CardioComm Solutions to Launch HeartCheck™ Technology for Atrial Fibrillation Screening and Stroke Prevention Trial in Canadian Rexall Pharmacies
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced it has completed its technology placement for the Canadian Stroke Prevention Intervention Network ("C-SPIN") and will implement its SMART Monitoring based HeartCheck™ ECG screening solution in select Rexall Pharmacies in October 2014.


JULY 28, 2014
Pharmacy.ca to Provide Internet-Based Pharmacy Sales of Cardiocomm Solutions' Heartcheck™ Pen ECG Device
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the HeartCheck™ ECG PEN device.


MAY 28, 2014
CardioComm Solutions Establishes Research Partnership with University of Texas at Austin for HeartCheck™ ECG Services in Clinical Neuroendocrinology.
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced it has entered into a partnership agreement with the Clinical Neuroendocrinology Laboratory at the University of Texas at Austin (UT-Austin). The agreement involves CardioComm Solutions supplying HeartCheck™ ECG recording devices and access to the Company's patent-pending SMART Monitoring ECG services to be used in screening research subjects for the presence or absence of medication induced cardiac abnormalities.


MAY 14, 2014
CardioComm Solutions' HeartCheck™ ECG PEN and GEMS™ Home Receive China Food and Drug Administration Clearance
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirms that China's Food and Drug Administration ("CFDA") has cleared the HeartCheck™ PEN ECG device and GEMS™ Home software for sale in China.


FEBRUARY 25, 2014
FDA Clears CardioComm Solutions' GUAVA II ECG Viewer with ECG Acquisition, Analysis, Interpretation, and Reporting Capabilities as a Class II Medical Device.
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirms U.S. Food and Drug Administration ("FDA") clearance of its GUAVA II ECG viewer technology as a Class II Medical Device.


FEBRUARY 7, 2014
CardioComm Solutions Completes Technology Pilot in the Long-Term Patient Care Market with the HeartCheck™ ECG Monitor and SMART Monitoring ECG Service Technologies.
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced that it is working within a pilot that uses HeartCheck™ ECG testing technology to support arrhythmia screening and surveillance with long-term care facilities. The pilot was coordinated by Toronto-based In Initiative Inc. and conducted with Responsive Management Inc. ("RMI"), an organization that owns and operates nine long-term care homes and three retirement residences in Ontario.